NHS National Framework for Transition products (Axitinib and Eltrombopag)

A Contract Award Notice
by NHS ENGLAND

Source
Find a Tender
Type
Framework ()
Duration
not specified
Value
£52M
Sector
MISCELLANEOUS
Published
30 Jul 2025
Delivery
not specified
Deadline
n/a

Concepts

Location

Geochart for 1 buyers and 7 suppliers

1 buyer

7 suppliers

Description

Project title: NHS National Framework for Transition products (Axitinib and Eltrombopag) commencing 1st October 2025 Offer reference number: CM/TNS/25/5722 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 48 months. Potential periods of call-offs under the framework agreement: CM/TNS/25/5722/01 Axitinib and Eltrombopag Lot 1 CESW: 01/10/2025 to 31/01/2027 (16 months) Lot 2 LSNE: 01/10/2025 to 31/05/2026 (8 months) Lot 3 NWLN: 01/10/2025 to 31/01/2027 (16 months) Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England Please note that the contract had erroneously been advertised as an open framework at the tender stage and should have been advertised as a standalone framework.

Award Detail

1 DR Reddys Laboratories (Cambridge)
  • NHS National Framework for Transition products (Axitinib and Eltrombopag)
  • Reference: 1
  • Value: £52,385,000 [share]
  • Awarded to group of suppliers.
2 Novartis Pharmaceuticals (London)
  • NHS National Framework for Transition products (Axitinib and Eltrombopag)
  • Reference: 1
  • Value: £52,385,000 [share]
  • Awarded to group of suppliers.
3 Perennial Pharma (Hatfield)
  • NHS National Framework for Transition products (Axitinib and Eltrombopag)
  • Reference: 1
  • Value: £52,385,000 [share]
  • Awarded to group of suppliers.
4 Pfizer (Kent)
  • NHS National Framework for Transition products (Axitinib and Eltrombopag)
  • Reference: 1
  • Value: £52,385,000 [share]
  • Awarded to group of suppliers.
5 Teva (Castleford)
  • NHS National Framework for Transition products (Axitinib and Eltrombopag)
  • Reference: 1
  • Value: £52,385,000 [share]
  • Awarded to group of suppliers.
6 Thornton & Ross (Huddersfield)
  • NHS National Framework for Transition products (Axitinib and Eltrombopag)
  • Reference: 1
  • Value: £52,385,000 [share]
  • Awarded to group of suppliers.
7 Wockhardt (Wrexham)
  • NHS National Framework for Transition products (Axitinib and Eltrombopag)
  • Reference: 1
  • Value: £52,385,000 [share]
  • Awarded to group of suppliers.

CPV Codes

  • None found

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

Domains